A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)

Clinical trial NCT03230916 · COMPLETED

Trial details

NCT number: NCT03230916
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Suspected or Documented Gram-negative Bacterial Infection

Start date: 2017-11-06
Primary completion: 2020-07-28
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.